Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EB-001 for facial scar reduction after Mohs surgery
NCT03346902Phase 2Completed
- Sponsor
- Bonti
- Start
- Feb 2018
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands, Bacterial Toxin Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of trenibotulinumtoxinE in surgical wound, sponsored by Bonti. Started Feb 2018; status: completed.
02
Drugs
trenibotulinumtoxinE
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT03346902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03346902.